News

“REPLACE Trial of Riociguat for Pulmonary Arterial Hypertension
5th September 2017

“REPLACE Trial of Riociguat for Pulmonary Arterial Hypertension

Dr Robin Condliffe and the Royal Hallamshire Clinical Research Facility are starting a trial of Riociguat, a drug for people with Pulmonary Arterial Hypertension (PAH). The trial is sponsored by Bayer PLC. Current PAH treatments include phosphodie...

Read More

STH success in national research league table
18th August 2017

STH success in national research league table

Sheffield Teaching Hospitals has been named in the top ten ‎research active NHS Trusts in the NIHR Research Activity League Table 2016-2017. Last year 11,490 patients took part in clinical research studies in STH, a 34% increase from the previ...

Read More

CF Health Hub Data Observatory
27th July 2017

CF Health Hub Data Observatory

A Quality Improvement project and Trials within Cohort platform for Cystic Fibrosis: The Data Observatory project aims to build on the work of the CFHealthHub and the ACTIF Programme Grant led by a Sheffield research team (Chief Investigators Dr ...

Read More

Cystic Fibrosis Annual Newlstter
27th June 2017

Cystic Fibrosis Annual Newlstter

The Sheffield Adult Cytic Fibrosis Centre has published its annual newsletter: down load it here: http://www.lungsheffield.org/clinical-services/newsletter

Read More

Patient guide to getting involve in clinical research
9th June 2017

Patient guide to getting involve in clinical research

The Sheffield Pulmonary Vascular Disease Unit, in collaboration with the UK Pulmonary Hypertension Association, has produced a guide for patients about getting involved in research, and about the pulmonary vascular research programme in Sheffield....

Read More

Trial for patients with "unclassifiable" pulmonary fibrosis
25th May 2017

Trial for patients with "unclassifiable" pulmonary fibrosis

Dr Stephen Bianchi and a research team from the Clinical Research Facility, Pharmacy, Labs and Respiratory Function Unit, are starting a new clinical trial for patients who have a type of pulmonary fibrosis which, for reasons unknown, cannot ...

Read More

New COPD Trial: “SOPHOS”
27th April 2017

New COPD Trial: “SOPHOS”

Metered Dose Inhalers (MDIs) are the most common type of device to deliver inhaled drugs to patients with Chronic Obstructive Pulmonary Disease. Yet many COPD treatments, particularly dual and triple combinations, have proven difficult to develop ...

Read More

New Mesothelioma trial: “TARGET”
30th March 2017

New Mesothelioma trial: “TARGET”

Dr Leon Lewis and Dr Duneesha De Fonseka are participating in a trial for patients who are being investigated for suspected mesothelioma. The principal research question is whether a PET-CT-targeted biopsy is more likely to give a diagnosis than a...

Read More

1st UK patients in clinical trial for Idiopathic Lung Fibrosis
13th February 2017

1st UK patients in clinical trial for Idiopathic Lung Fibrosis

A study team from Sheffield Teaching Hospitals Respiratory Medicine have recruited the 1st and 2nd UK patients to take part in a clinical trial of a new type of treatment for the condition idiopathic lung fibrosis (IPF). Consultant Dr Stephen Bia...

Read More

Clinical Research Publications
3rd January 2017

Clinical Research Publications

The Sheffield Academic Directorate of Respiratory Medicine contributed to a number of clinical research articles which were published in 2016. A listing with links can be found on our Publications page: see www.lungsheffield.org/research...

Read More